Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 107, Issue 9, Pages djv154-djv154
Publisher
Oxford University Press (OUP)
Online
2015-06-11
DOI
10.1093/jnci/djv154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer
- (2015) Mads Duus Hjortsø et al. OncoImmunology
- Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
- (2014) Benoit Marchand et al. CANCER RESEARCH
- The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity
- (2014) S M Ahmad et al. Blood Cancer Journal
- Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
- (2013) T. Z. Iversen et al. CLINICAL CANCER RESEARCH
- Functional characterization of Foxp3-specific spontaneous immune responses
- (2013) S K Larsen et al. LEUKEMIA
- Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells
- (2013) S Munir et al. LEUKEMIA
- Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway
- (2013) S M Ahmad et al. LEUKEMIA
- Immunologic Targeting of FOXP3 in Inflammatory Breast Cancer Cells
- (2013) Smita Nair et al. PLoS One
- FOXP3-specific immunity
- (2013) Mads Andersen OncoImmunology
- The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+T cells
- (2013) Shamaila Munir et al. OncoImmunology
- Selection of Self-Reactive T Cells in the Thymus
- (2012) Gretta L. Stritesky et al. Annual Review of Immunology
- The role of B7 family molecules in hematologic malignancy
- (2012) P. Greaves et al. BLOOD
- The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
- (2012) Mads Hald Andersen CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells
- (2012) Arthur A. Hurwitz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)
- (2012) Suzanne Ostrand-Rosenberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment
- (2012) Z. Zhu et al. CANCER RESEARCH
- Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma
- (2012) H Tamura et al. LEUKEMIA
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase
- (2012) Shamaila Munir et al. PLoS One
- CD4 responses against IDO
- (2012) Mads Hald Andersen OncoImmunology
- FOXO3
- (2012) Stephanie K. Watkins et al. OncoImmunology
- Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2
- (2011) R. B. Sorensen et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
- (2011) Stephanie K. Watkins et al. JOURNAL OF CLINICAL INVESTIGATION
- Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma
- (2011) N W C J van de Donk et al. LEUKEMIA
- Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
- (2011) T Krejsgaard et al. LEUKEMIA
- Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells
- (2011) P Amé-Thomas et al. LEUKEMIA
- Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination
- (2011) Per thor Straten et al. VACCINE
- Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
- (2010) R. B. Sorensen et al. BLOOD
- Identification of heme oxygenase-1–specific regulatory CD8+ T cells in cancer patients
- (2009) Mads Hald Andersen et al. JOURNAL OF CLINICAL INVESTIGATION
- The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase
- (2009) Rikke Bæk Sørensen et al. PLoS One
- Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer
- (2009) L. A. Vella et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
- (2008) T Kozako et al. LEUKEMIA
- Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan
- (2008) Yoshika Nagata et al. LUNG CANCER
- Immune escape as a fundamental trait of cancer: focus on IDO
- (2008) G C Prendergast ONCOGENE
- Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation
- (2008) H. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started